Works matching IS 22351795 AND DT 2022 AND VI 11


Results: 68
    2

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 1, doi. 10.1159/000528495
    Publication type:
    Article
    3

    Contents Vol. 11, 2022.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. I, doi. 10.1159/000528106
    Publication type:
    Article
    4

    APPLE News.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 582, doi. 10.1159/000528105
    Publication type:
    Article
    5
    6
    7
    8

    Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition).

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 511, doi. 10.1159/000526038
    By:
    • Yang, Yu;
    • Sun, Juxian;
    • Wu, Mengchao;
    • Lau, Wan Yee;
    • Zheng, Shusen;
    • Wang, Xue-Hao;
    • Chen, Xiaoping;
    • Fan, Jia;
    • Dong, Jiahong;
    • Cai, Jianqiang;
    • Chen, Minshan;
    • Chen, Yongjun;
    • Cheng, Zhangjun;
    • Dai, Chaoliu;
    • Shan, Jianzhen;
    • Du, Cheng-You;
    • Fang, Chihua;
    • Hu, Heping;
    • Ji, Zhili;
    • Jia, Weidong
    Publication type:
    Article
    9
    10

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    11
    12
    13

    Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 540, doi. 10.1159/000525375
    By:
    • Zaki, Marco Y.W.;
    • Alhasan, Sari F.;
    • Shukla, Ruchi;
    • McCain, Misti;
    • Laszczewska, Maja;
    • Geh, Daniel;
    • Patman, Gillian L.;
    • Televantou, Despina;
    • Whitehead, Anna;
    • Maurício, João P.;
    • Barksby, Ben;
    • Gee, Lucy M.;
    • Paish, Hannah L.;
    • Leslie, Jack;
    • Younes, Ramy;
    • Burt, Alastair D.;
    • Borthwick, Lee A.;
    • Thomas, Huw;
    • Beale, Gary S.;
    • Govaere, Olivier
    Publication type:
    Article
    14

    Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 527, doi. 10.1159/000525145
    By:
    • Casadei-Gardini, Andrea;
    • Rimini, Margherita;
    • Kudo, Masatoshi;
    • Shimose, Shigeo;
    • Tada, Toshifumi;
    • Suda, Goki;
    • Goh, Myung Ji;
    • Jefremow, Andre;
    • Scartozzi, Mario;
    • Cabibbo, Giuseppe;
    • Campani, Claudia;
    • Tamburini, Emiliano;
    • Tovoli, Francesco;
    • Ueshima, Kazuomi;
    • Aoki, Tomoko;
    • Iwamoto, Hideki;
    • Torimura, Takuji;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Atsukawa, Masanori
    Publication type:
    Article
    15
    16

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 1, doi. 10.1159/000526882
    Publication type:
    Article
    17
    18

    Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 426, doi. 10.1159/000525582
    By:
    • Yau, Thomas;
    • Tai, David;
    • Chan, Stephen Lam;
    • Huang, Yi-Hsiang;
    • Choo, Su Pin;
    • Hsu, Chiun;
    • Cheung, Tan To;
    • Lin, Shi-Ming;
    • Yong, Wei Peng;
    • Lee, Joycelyn;
    • Leung, Thomas;
    • Shum, Tracy;
    • Yeung, Cynthia S.Y.;
    • Tai, Anna Yin-Ping;
    • Law, Ada Lai Yau;
    • Cheng, Ann-Lii;
    • Chen, Li-Tzong
    Publication type:
    Article
    19

    Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 440, doi. 10.1159/000525500
    By:
    • Ikeda, Masafumi;
    • Arai, Yasuaki;
    • Inaba, Yoshitaka;
    • Tanaka, Toshihiro;
    • Sugawara, Shunsuke;
    • Kodama, Yoshihisa;
    • Aramaki, Takeshi;
    • Anai, Hiroshi;
    • Morita, Shinichi;
    • Tsukahara, Yoshinori;
    • Seki, Hiroshi;
    • Sato, Mikio;
    • Kamimura, Kenya;
    • Azama, Kimei;
    • Tsurusaki, Masakatsu;
    • Sugihara, Eiji;
    • Miyazaki, Masaya;
    • Kobayashi, Tatsushi;
    • Sone, Miyuki
    Publication type:
    Article
    20

    Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 451, doi. 10.1159/000525489
    By:
    • Chan, Stephen Lam;
    • Chotipanich, Chanisa;
    • Choo, Su Pin;
    • Kwang, Su Wen;
    • Mo, Frankie;
    • Worakitsitisatorn, Akeanong;
    • Tai, David;
    • Sundar, Raghav;
    • Ng, David Chee Eng;
    • Loke, Kelvin Siu Hoong;
    • Li, Leung;
    • Ng, Kelvin Kwok Chai;
    • Peng, Yong Wei;
    • Yu, Simon Chun-Ho
    Publication type:
    Article
    21

    Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 460, doi. 10.1159/000525488
    By:
    • Gigante, Elia;
    • Hobeika, Christian;
    • Le Bail, Brigitte;
    • Paradis, Valérie;
    • Tougeron, David;
    • Lequoy, Marie;
    • Bouattour, Mohamed;
    • Blanc, Jean-Frederic;
    • Ganne-Carrié, Nathalie;
    • Tran, Henri;
    • Hollande, Clémence;
    • Allaire, Manon;
    • Amaddeo, Giuliana;
    • Regnault, Hélène;
    • Vigneron, Paul;
    • Ronot, Maxime;
    • Elkrief, Laure;
    • Verset, Gontran;
    • Trepo, Eric;
    • Zaanan, Aziz
    Publication type:
    Article
    22
    23
    24

    Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 407, doi. 10.1159/000524893
    By:
    • Ueshima, Kazuomi;
    • Komemushi, Atsushi;
    • Aramaki, Takeshi;
    • Iwamoto, Hideki;
    • Obi, Shuntaro;
    • Sato, Yozo;
    • Tanaka, Toshihiro;
    • Matsueda, Kiyoshi;
    • Moriguchi, Michihisa;
    • Saito, Hiroya;
    • Sone, Miyuki;
    • Yamagami, Takuji;
    • Inaba, Yoshitaka;
    • Kudo, Masatoshi;
    • Arai, Yasuaki
    Publication type:
    Article
    25

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 1, doi. 10.1159/000525876
    Publication type:
    Article
    26

    APPLE News.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 398, doi. 10.1159/000525668
    Publication type:
    Article
    27
    28

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    29
    30

    Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 368, doi. 10.1159/000523849
    By:
    • Xia, Dongdong;
    • Bai, Wei;
    • Wang, Enxin;
    • Li, Jiaping;
    • Chen, Xiaoming;
    • Wang, Zhexuan;
    • Huang, Mingsheng;
    • Huang, Ming;
    • Sun, Junhui;
    • Yang, Weizhu;
    • Lin, Zhengyu;
    • Wu, Jianbing;
    • Li, Zixiang;
    • Yang, Shufa;
    • Zhu, Xu;
    • Chen, Zaizhong;
    • Zhang, Yanfang;
    • Fan, Wenzhe;
    • Mai, Qicong;
    • Ding, Rong
    Publication type:
    Article
    31

    Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 354, doi. 10.1159/000522547
    By:
    • Kudo, Masatoshi;
    • Ueshima, Kazuomi;
    • Ikeda, Masafumi;
    • Torimura, Takuji;
    • Tanabe, Nobukazu;
    • Aikata, Hiroshi;
    • Izumi, Namiki;
    • Yamasaki, Takahiro;
    • Nojiri, Shunsuke;
    • Hino, Keisuke;
    • Tsumura, Hidetaka;
    • Kuzuya, Teiji;
    • Isoda, Norio;
    • Moriguchi, Michihisa;
    • Aino, Hajime;
    • Ido, Akio;
    • Kawabe, Naoto;
    • Nakao, Kazuhiko;
    • Wada, Yoshiyuki;
    • Ogasawara, Sadahisa
    Publication type:
    Article
    32

    Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 383, doi. 10.1159/000522424
    By:
    • Kuroda, Hidekatsu;
    • Oikawa, Takayoshi;
    • Ninomiya, Masashi;
    • Fujita, Masashi;
    • Abe, Kazumichi;
    • Okumoto, Kazuo;
    • Katsumi, Tomohiro;
    • Sato, Wataru;
    • Igarashi, Go;
    • Iino, Chikara;
    • Endo, Tetsu;
    • Tanabe, Nobukazu;
    • Numao, Hiroshi;
    • Fukuda, Shinsaku;
    • Iijima, Katsunori;
    • Masamune, Atsushi;
    • Ohira, Hiromasa;
    • Ueno, Yoshiyuki;
    • Takikawa, Yasuhiro
    Publication type:
    Article
    33

    Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 290, doi. 10.1159/000522403
    By:
    • Kubo, Shoji;
    • Shinkawa, Hiroji;
    • Asaoka, Yoshinari;
    • Ioka, Tatsuya;
    • Igaki, Hiroshi;
    • Izumi, Namiki;
    • Itoi, Takao;
    • Unno, Michiaki;
    • Ohtsuka, Masayuki;
    • Okusaka, Takuji;
    • Kadoya, Masumi;
    • Kudo, Masatoshi;
    • Kumada, Takashi;
    • Kokudo, Norihiro;
    • Sakamoto, Michiie;
    • Sakamoto, Yoshihiro;
    • Sakurai, Hideyuki;
    • Takayama, Tadatoshi;
    • Nakashima, Osamu;
    • Nagata, Yasushi
    Publication type:
    Article
    34

    Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 329, doi. 10.1159/000522389
    By:
    • Yamasaki, Takahiro;
    • Saeki, Issei;
    • Yamauchi, Yurika;
    • Matsumoto, Toshihiko;
    • Suehiro, Yutaka;
    • Kawaoka, Tomokazu;
    • Uchikawa, Shinsuke;
    • Hiramatsu, Akira;
    • Aikata, Hiroshi;
    • Kobayashi, Kazufumi;
    • Kondo, Takayuki;
    • Ogasawara, Sadahisa;
    • Chiba, Tetsuhiro;
    • Takami, Taro;
    • Chayama, Kazuaki;
    • Kato, Naoya;
    • Sakaida, Isao
    Publication type:
    Article
    35
    36

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 1, doi. 10.1159/000525471
    Publication type:
    Article
    37

    APPLE News.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 281, doi. 10.1159/000525224
    Publication type:
    Article
    38
    39

    First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 268, doi. 10.1159/000522418
    By:
    • Harding, James J.;
    • Awada, Ahmad;
    • Roth, Gael;
    • Decaens, Thomas;
    • Merle, Philippe;
    • Kotecki, Nuria;
    • Dreyer, Chantal;
    • Ansaldi, Christelle;
    • Rachid, Madani;
    • Mezouar, Soraya;
    • Menut, Agnes;
    • Bestion, Eloïne Nadeige;
    • Paradis, Valérie;
    • Halfon, Philippe;
    • Abou-Alfa, Ghassan K.;
    • Raymond, Eric
    Publication type:
    Article
    40
    41
    42
    43

    Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 219, doi. 10.1159/000521746
    By:
    • Welland, Sabrina;
    • Leyh, Catherine;
    • Finkelmeier, Fabian;
    • Jefremow, André;
    • Shmanko, Kateryna;
    • Gonzalez-Carmona, Maria A.;
    • Kandulski, Arne;
    • Jeliazkova, Petia;
    • Best, Jan;
    • Fründt, Thorben W.;
    • Djanani, Angela;
    • Pangerl, Maria;
    • Maieron, Andreas;
    • Greil, Richard;
    • Fricke, Christina;
    • Sookthai, Disorn;
    • Günther, Rainer;
    • Schmiderer, Andreas;
    • Wege, Henning;
    • Venerito, Marino
    Publication type:
    Article
    44

    Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial).

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 209, doi. 10.1159/000521665
    By:
    • Takayama, Tadatoshi;
    • Hasegawa, Kiyoshi;
    • Izumi, Namiki;
    • Kudo, Masatoshi;
    • Shimada, Mitsuo;
    • Yamanaka, Naoki;
    • Inomata, Masafumi;
    • Kaneko, Shuichi;
    • Nakayama, Hisashi;
    • Kawaguchi, Yoshikuni;
    • Kashiwabara, Kosuke;
    • Tateishi, Ryosuke;
    • Shiina, Shuichiro;
    • Koike, Kazuhiko;
    • Matsuyama, Yutaka;
    • Omata, Masao;
    • Makuuchi, Masatoshi;
    • Kokudo, Norihiro
    Publication type:
    Article
    45
    46
    47

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 1, doi. 10.1159/000524556
    Publication type:
    Article
    48

    APPLE News.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 184, doi. 10.1159/000524373
    Publication type:
    Article
    49
    50